| Literature DB >> 28830484 |
Grzegorz Guzik1,2.
Abstract
BACKGROUND: In nearly 30% of patients with myeloma, pathological fractures are found to occur in the spine. If the patients are not treated promptly and satisfactorily, the quality of their lives diminishes. Currently, the standard treatment for metastatic lesions of the spine is radiotherapy, but surgical intervention is becoming more frequent. It is very important to quickly identify metastases and implement surgical treatment before any fracture/s occur.Entities:
Keywords: Metastases; Multiple myeloma; Resections; Spinal tumours; Spine surgery; Stabilization
Mesh:
Year: 2017 PMID: 28830484 PMCID: PMC5568288 DOI: 10.1186/s12893-017-0288-9
Source DB: PubMed Journal: BMC Surg ISSN: 1471-2482 Impact factor: 2.102
Fig. 1Myeloma metastasis to C2 and C3 (a) and radiograms after surgery (vertebral body prosthesis of C3 and the plate fixation, dens axis vertebroplasty) (b)
Fig. 2The type of pain in patients depending on a pathological fracture of the vertebral column
Baseline clinical characteristics and examination findings in patients with myeloma metastases in the vertebral column. N = 129
| Variables |
|
| Fracture | 98 (76) |
| Multi level involvement | 119 (92) |
| Vertebral body involvement | 98 (76) |
| Spinal canal stenosis | 54 (42) |
| Soft tissue mass | 31 (24) |
| Orthopedic examination elements | |
| Spinal axis disorder | 68 (53) |
| Reflex scoliosis | 61 (47) |
| Increased paraspinal muscle tension | 94 (73) |
| Spinal pain on spinous processes | 112 (87) |
| Pain on axial compression by pressing the head | 86 (67) |
| Reduced mobility of the spine | 114 (88) |
| Pain on movement | 98 (76) |
Results are presented as a number with a percentage
Fig. 3Survival of the patients according to type of vertebral involvment. N = 129
Analysis of numerous factors that might be related to overall survival
| Number of patients |
| |
|---|---|---|
| Age | ||
| < 65 years | 43 (33%) | <0.05 |
| > 65 years | 86 (67%) | <0.05 |
| Stage of disease (Salmon-Durie) | ||
| I | 8 (6%) | Ns |
| II | 20 (16%) | Ns |
| III | 101(78%) | <0.05 |
| Radiotherapy | ||
| Yes | 85 (66%) | Ns |
| No | 44 (34%) | Ns |
| Time to initial diagnosis | ||
| < 1 year | 23 (8%) | Ns |
| 1–2 years | 48 (37%) | Ns |
| > 3 years | 71 (55%) | <0.05 |
| CRP level | ||
| < 5 mg/l | 91 (70%) | Ns |
| > 5 mg/l | 38 (30%) | Ns |
| Peripheral blood stem cell transplantation | ||
| Yes | 71 (55%) | Ns |
| No | 58 (45%) | Ns |
| Lactate dehydrogenase | ||
| < 240 U/l | 93 (72%) | Ns |
| > 240 U/l | 36 (28%) | Ns |
| Beta-2 microglobulin | ||
| < 3.5 mg/l | 8 (6%) | Ns |
| 3.5–5.5 mg/l | 31 (24%) | Ns |
| > 5.5 mg/l | 90 (70%) | Ns |
Frequency of potential contraindications to vertebroplasty in our group of patients
| Potential contraindications to vertebroplasty | Patients qualified to vertebroplasty | Patients qualified to spine stabilizations |
|---|---|---|
| Impairment of the neural elements | No | 21(37%) |
| Cauda equine syndrome | No | 6(11%) |
| Spine kyphosis | 12(16%) | 56 (100%) |
| Fractures with obstructing plasmocytoma | No | 31(55%) |
| Retropulsed bone | No | 56(100%) |
| Vertebra plana | No | 15(27%) |
| Disruption of the posterior vertebral body cortex | No | 54(96%) |
| Unstable spine | 47 (64%) | 56(100%) |
| Metal or PMMA alergy | No | No |
| Coagulopathy | No | No |
| Neutropenia | 6(8%) | 2(4%) |
| Cardio-pulmonary insufficiency | No | No |
| Radiotherapy before surgery | 2(3%) | 4(7%) |
| Skin infections | No | No |
Mean results of the VAS score and the Karnofsky performance score in patients before and after surgery, and after different treatment methods
| Treatment option | VAS score | Karnofsky score | ||
|---|---|---|---|---|
| Preoperative | Postoperative | Preoperative | Postoperative | |
| Patients after vertebroplasty | 5,3 (±1.8) | 1,4 (±0.9)* | 60 (±7.9) | 80 (±5.6)* |
| Patients after stabilization | 8.1 (±0.6) | 4.4 (±1.1)* | 54 (±9.8) | 59 (±12.2) |
| Anterior stabilization | 7.5 (±1.2) | 4.7 (±1.0) | 52 (±8.0) | 58 (±9.2) |
| Posterior stabilization | 8.0 (±0.4) | 4.1 (±0.6)* | 56 (±5.5) | 62 (±5.5) |
| Combine stabilization | 9.2 (±1.6) | 4.5 (±0.9)* | 49 (±11) | 55 (±10) |
| Vertebroplasty vs. Stabilization | p = <0.05 | p = <0.05 | NS |
|
Results are presented as a mean ± standard deviation
* p < 0.05
Neurological status in patients before and after the surgery, and after different treatment methods
| Neurological Status | Posterior stabilization | Combine stabilization | ||
|---|---|---|---|---|
| Preoperative | Postoperative | Preoperative | Postoperative | |
| Frankel A | 5 (11) | 3 (7) | 1 (12) | 0 |
| Frankel B | 5 (11) | 2 (5)* | 0 | 1 (12) |
| Frankel C | 3 (7) | 2 (5) | 1 (12) | 1 (12) |
| Frankel D | 2 (5) | 0 | 0 | 0 |
| Sensory impairments | 4 (9) | 2 (5)* | 0 | 0 |
Results are presented as a number with a percentage
* p < 0.05 χ2
Systemic complication after surgery in patients with myeloma metastases in thevertebral column
| Treatment option | Systemic complication | ||
|---|---|---|---|
| Surgical wound infections | Pulmonary embolism | Local recurrence | |
| Patiens after vertebroplasty | 0 | 1 (1.3) | 0 |
| Patients after stabilization | 3 (5) | 2 (3.6) | 12 (22) |
Results are presented as a number with a percentage